The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience

The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience

Abstract Background Pseudomyogenic hemangioendothelioma (PHE) is a rare, locally aggressive vascular tumor. Less than 200 cases of PHE have been reported. Surgery is the cornerstone of PHE treatment, and the data on systemic treatment is limited. Methods A retrospective multicenter study was conduct...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiyan Cai, Bushu Xu, Peng Zhang, Jie Ma, Jiahui Liang, Liyuan Le, Shining Li, Jing Yang, Qiuzhong Pan, Ruiqing Peng, Xing Zhang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Pseudomyogenic hemangioendothelioma
Vascular tumor
Clinical feature
Systemic therapy
Gemcitabine and docetaxel
Online Access:https://doi.org/10.1186/s12885-025-14376-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14376-6

Similar Items